Residency Application
Accredited by PDS

The Skin and Cancer Foundation, Inc. (SCFI) is one of the eleven residency training institutions accredited by the Philippine Dermatological Society (PDS). It is the second residency training program to be approved by the PDS. The PDS, in turn, is the only specialty society for Dermatology accredited by the Philippine Medical Association (PMA) and the Philippine College of Physicians (PCP).

 

« GENERATIONAL AESTHETICS: Closing the Gap through Dermatology | Main | World Psoriasis Day 2022: STOP THE STIGMA NOW! »
Tuesday
Nov082022

Residency Applications for 2023 BATCH 2 is extended!

APPLICATION FOR THE 2ND BATCH OF PRE-RESIDENTS IS NOW EXTENDED!!!
The Skin and Cancer Foundation, Inc. is accepting a 2nd batch of applicants for it’s PDS-Accredited 3-year Dermatology Residency Training Program for the year 2023! ✨
Deadline of submission is on November 10, 2022 (12:00 Noon)
Interview will be on November 11, 2022 (3:00 PM)
For inquiries:
Mon-Sat (10:00AM - 1:00PM)
Tel No. (632) 8638-7871
Email: scfidermatology@gmail.com
Mon-Fri (10:00AM - 5:00PM)
Dr. Pamela Sogono, Chief Resident
0917 545 2924 (via Viber only)
Website: http://www.skinandcancerfoundationmanila.org
Facebook: https://www.facebook.com/SkinAndCancerFoundationInc

APPLICATION FOR THE 2ND BATCH OF PRE-RESIDENTS IS NOW EXTENDED!!!
The Skin and Cancer Foundation, Inc. is accepting a 2nd batch of applicants for it’s PDS-Accredited 3-year Dermatology Residency Training Program for the year 2023! ✨
Deadline of submission is on November 10, 2022 (12:00 Noon)Interview will be on November 11, 2022 (3:00 PM)
For inquiries:Mon-Sat (10:00AM - 1:00PM)Tel No. (632) 8638-7871Email: scfidermatology@gmail.com
Mon-Fri (10:00AM - 5:00PM)Dr. Pamela Sogono, Chief Resident0917 545 2924 (via Viber only)
Website: http://www.skinandcancerfoundationmanila.orgFacebook: https://www.facebook.com/SkinAndCancerFoundationInc

 

Reader Comments

There are no comments for this journal entry. To create a new comment, use the form below.

PostPost a New Comment

Enter your information below to add a new comment.

My response is on my own website »
Author Email (optional):
Author URL (optional):
Post:
 
Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>